Market Research & Insights
Clarivate patient centricity report underscores need for evolution from selling products to building relationships
Clarivate, a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced the release […]
MoreMarket Research & Insights
The future of the generics landscape: Key branded drugs losing exclusivity in 2021 and beyond
Clarivate, a global leader in providing trusted information and insights to accelerate the pace of innovation, announced the launch of […]
MoreMarket Research & Insights
Patient centricity has long been at the heart of medical innovation, but today shapes its future
Clarivate, a global leader in providing trusted information and insights to accelerate the pace of innovation, announced the launch of […]
MoreMarket Research & Insights
Clarivate forecasts nearly 70% of Asia Pacific, North American and European adult populations will be vaccinated for COVID-19 by September 2021
A new report analyses how the emergence and increased availability of vaccines will impact the recovery of healthcare markets across […]
MoreMarket Research & Insights
2021 outlook for pharma mergers and acquisitions
Market Research & Insights: A recent PwC report indicated an optimistic 2021 for the pharmaceutical and life sciences (PLS) sector […]
MoreMarket Research & Insights
What high-performing MedTech companies are doing differently
Market Research & Insights: Innovation and product development (I&PD) in the MedTech sector is costly. A strong I&PD strategy can help […]
MoreMarket Research & Insights
New report identifies skills priorities for future workforce of Pharma, MedTech and Biotech
Market Research & Insights
MedTech leaders prioritise innovation and technology
Please log in to Health Industry Hub to view this content in the Market Research & Insights menu.
Market Research & Insights
Workforce gaps in Australian MedTech, Pharma, Biotech and digital health sectors
Australia’s medical technology, biotechnology, pharmaceutical and digital health sector supports approximately 70,000 Australian jobs and contributed more than $5 billion […]
MoreMarket Research & Insights
New report highlights impact of COVID-19 on cancer screening
Please log in to Health Industry Hub to view this content in the Medical sub-menu.
Recent Posts in Pharma, MedTech & Biotech
Policy paralysis: Private hospitals left to clean up the government’s mess on medical device reforms
April 17, 2025
in News & Trends - MedTech & Diagnostics
Oncologists pioneer liquid biopsy-guided treatment in lung cancer
April 17, 2025
in News & Trends - Pharmaceuticals
The high cost of record low research funding
April 17, 2025
in Medical and Science
UCB secures dermatology indication with first dual IL-17A/F inhibitor
April 17, 2025
in News & Trends - Pharmaceuticals
New Medicines Australia policy leader critical to HTA reforms
April 15, 2025
in Leadership & Management
How Australia’s employee engagement measures up
April 15, 2025
in Human Resources
PBAC issues criticism of pharma industry’s reimbursement submissions
April 15, 2025
in News & Trends - Pharmaceuticals
Surgeons warn patient care at risk as government drags its feet
April 15, 2025
in News & Trends - MedTech & Diagnostics
Follow Us
Partner with us
News & Trends - MedTech & Diagnostics
Policy paralysis: Private hospitals left to clean up the government’s mess on medical device reforms
Hospitals shouldn’t be forced to grovel to private health insurers to secure funding for essential, lifesaving medical devices. But thanks […]
MoreNews & Trends - Pharmaceuticals
Oncologists pioneer liquid biopsy-guided treatment in lung cancer
Lung cancer is Australia’s leading cause of cancer deaths. Local experts are set to lead a new frontier in personalised […]
MoreMedical and Science
The high cost of record low research funding
Australia has delivered some of the world’s most transformative health and medical breakthroughs – the cochlear implant, the HPV vaccine, […]
MoreNews & Trends - Pharmaceuticals
UCB secures dermatology indication with first dual IL-17A/F inhibitor
UCB’s IL-17A and IL-17F inhibitor has been added to the Australian Register of Therapeutic Goods (ARTG) for adults with moderate […]
More